Seeking Alpha

3B NEXUS's  Instablog

3B NEXUS
Send Message
Enterprise Online Video Platform & Portal - for Investors, Corporates and Market Specialists & Media. Software-as-a-Service (SaaS) video hosting and streaming solution that helps content owners ingest, transcode, store, manage, protect, publish, syndicate, track and monetize online... More
My company:
3B NEXUS
My blog:
Bulls Bears & Butterflies®
  • Corporate Webcast: Apogenix GmbH APG101 – A Novel Approach For The Treatment Of Cancer. 0 comments
    Apr 25, 2012 9:41 AM

    Apogenix GmbH APG101 - A Novel Approach for the Treatment of Cancer.

    APG101 is a human fusion protein consisting of the extracellular domain of the CD95 receptor fused to the IgG part of an antibody. It binds to the CD95 ligand, thereby blocking the interaction with its cognate receptor. Whereas this interaction triggers apoptosis in many cells, it stimulates invasive growth in cancer cells. Blocking CD95 mediated tumor growth thus represents a novel concept to treating cancer.

    Broadcast live, record and publish your investor, corporate and analyst videos on 3B NEXUS for our targeted distribution. 3bnexus.com

Back To 3B NEXUS's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.